LV12458A - Binding and Pharmaceutical Compositions for Changing Treatments for Related Diseases by Triptase Activity - Google Patents

Binding and Pharmaceutical Compositions for Changing Treatments for Related Diseases by Triptase Activity

Info

Publication number
LV12458A
LV12458A LV000030A LV000030A LV12458A LV 12458 A LV12458 A LV 12458A LV 000030 A LV000030 A LV 000030A LV 000030 A LV000030 A LV 000030A LV 12458 A LV12458 A LV 12458A
Authority
LV
Latvia
Prior art keywords
triptase
binding
activity
pharmaceutical compositions
related diseases
Prior art date
Application number
LV000030A
Other languages
Latvian (lv)
Other versions
LV12458B (en
Inventor
Jeffrey Mark Dener
Elaine Yee-Lin Kuo
Ken Duane Rice
Vivian Rucyven Wang
Wendy Beth Young
Original Assignee
Arris Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1997/013422 external-priority patent/WO1998004537A1/en
Application filed by Arris Pharm Corp filed Critical Arris Pharm Corp
Publication of LV12458A publication Critical patent/LV12458A/en
Publication of LV12458B publication Critical patent/LV12458B/en

Links

Abstract

The present invention relates to novel compounds which are tryptase inhibitors; the pharmaceutically acceptable salts and N oxides thereof; their uses as therapeutic agents and the methods of their making.
LVP-00-30A 1996-07-30 2000-02-25 Novel compounds and compositions for treating diseases associated with tryptase activity LV12458B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2313996P 1996-07-30 1996-07-30
US89577297A 1997-07-17 1997-07-17
PCT/US1997/013422 WO1998004537A1 (en) 1996-07-30 1997-07-30 Novel compounds and compositions for treating diseases associated with tryptase activity
LVP-99-27A LV12291B (en) 1996-07-30 1999-02-18 Novel compounds and compositions for treating diseases associated with tryptase activity

Publications (2)

Publication Number Publication Date
LV12458A true LV12458A (en) 2000-04-20
LV12458B LV12458B (en) 2000-09-20

Family

ID=27350794

Family Applications (2)

Application Number Title Priority Date Filing Date
LVP-00-30A LV12458B (en) 1996-07-30 2000-02-25 Novel compounds and compositions for treating diseases associated with tryptase activity
LVP-00-31A LV12459B (en) 1996-07-30 2000-02-25 Novel compounds and compositions for treating diseases associated with tryptase activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
LVP-00-31A LV12459B (en) 1996-07-30 2000-02-25 Novel compounds and compositions for treating diseases associated with tryptase activity

Country Status (1)

Country Link
LV (2) LV12458B (en)

Also Published As

Publication number Publication date
LV12459A (en) 2000-04-20
LV12459B (en) 2000-09-20
LV12458B (en) 2000-09-20

Similar Documents

Publication Publication Date Title
LV12291A (en) Compound and pharmaceutical compositions for the treatment of related diseases by triptase activity
DE60114994D1 (en) PLATELET ADP RECEPTOR INHIBITORS
DK1346041T3 (en) Therapeutic agents and methods for their use in the treatment of an amyloidogenic disease
BG66085B1 (en) Phenylalanine derivatives
FI20115753A (en) Pharmaceutical compositions for the treatment of diseases caused by IL-6 production
BR0115411A (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases.
DK0778834T3 (en) Bicyclic heterocyclic diaryl compounds as inhibitors of cyclooxygenase-2
EE200100485A (en) Novel Compounds and Compositions as Protease Inhibitors
EA199900778A1 (en) HETEROCYCLIC COMPOUNDS AND THEIR USE TO INHIBIT β-AMYLOID PEPTIDE
BR0210122A (en) Compound or a pharmaceutically acceptable salt thereof, method for treating or preventing a disease, use of the compound or salt thereof, and method for preparing the same
ATE269865T1 (en) PYRAZOLO(3,4-G)QUINOXALINE AS PDGF RECEPTOR PROTEIN TYROSINE KINASE INHIBITORS
DE69824313D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING SIBUTRAMINE AND ORLISTAT
EA200301203A1 (en) NEW COMPOUNDS AND COMPOSITIONS AS KATEPSIN INHIBITORS
SE0102440D0 (en) New compound
DE69819539D1 (en) ANTITHROMBOTIC AGENTS
EA200100140A1 (en) THERAPEUTIC COMPOSITION ON THE BASIS OF FLAVONOIDS FOR APPLICATION IN TREATMENT OF TUMORS BY CYTOTOXIC AGENTS
DK0758312T3 (en) Substituted fused and bridged bicyclic compounds as therapeutic agents
ID21369A (en) PHARMACEUTICAL COMPOSITION FOR HEALING OF DISEASES CAUSED BY VIRUS
DE69828522D1 (en) ANTITROMOMBOTIC AGENTS
SE0004827D0 (en) Therapeutic compounds
LV12458A (en) Binding and Pharmaceutical Compositions for Changing Treatments for Related Diseases by Triptase Activity
PT1337246E (en) UTILIZATION OF 6-DIMETHYLAMINOMETHYL-1-PHENYLCYLOHEXANE COMPOUNDS FOR URINARY INCONTINENCE THERAPY
EA200401295A1 (en) STATIN THERAPY TO ENHANCE SUPPORT OF COGNITIVE FUNCTION
SE9900190D0 (en) New compounds
HUP9801925A3 (en) Use of sodium-hydrogen-exchange-inhibitors for producing pharmaceutical compositions treating diseases caused by protozoons